Global Dna Sequencing Market Growth Rate 2024, Forecast To 2033
8 Mar, 2024
DNA sequencing market surged from $11.84 billion in 2023 to $13.68 billion in 2024, with a CAGR of 15.6%. Predicted to reach $24.49 billion by 2028, growing at a CAGR of 15.7%. Next-gen sequencing advancements and precision medicine adoption will drive growth, alongside trends like single-cell sequencing and liquid biopsy development.
Global DNA Sequencing Market Key Driver
The increasing prevalence of cancer is expected to propel the growth of the DNA sequencing market. DNA sequencing plays a crucial role in identifying genetic mutations and guiding treatment decisions, with the number of cancer cases projected to rise significantly. For instance, in October 2022, Macmillan Cancer Support estimated that the number of people with cancer would increase to 3.5 million by 2025 and 5.3 million by 2040.
Get A Free Sample Of The Global DNA Sequencing Market ReportGlobal DNA Sequencing Market Segments
The dna sequencing market covered in this report is segmented –
1) Product:Instruments, Consumables, Services
2) Technology:Third Generation DNA Sequencing, Next-Generation Sequencing, Sanger Sequencing
3) Application:Diagnostics, Biomarkers And Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications
4) End User:Hospitals And Healthcare Organizations, Academics And Research Institutions, Pharmaceutical And Biotechnology Companies, Other End Users
By Geography: The countries covered in the dna sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the DNA sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major DNA Sequencing Industry Players
F. Hoffmann-La Roche Ltd; Abbott Laboratories Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers AG; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; BGI Genomics; Myriad Genetics Inc.; Natera Inc.; 10x Genomics Inc.; GenScript Biotech Corporation; Novogene Corporation; Twist Bioscience; Genewiz LLC; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California Inc.; Macrogen Inc.; LI-COR Inc.; MGI Tech Co. Ltd.; Zymo Research Corporation; Igenomix; Codex DNA; GenapSys Inc.; SeqOnce Biosciences Inc.
Get The Full Global DNA Sequencing Market Report
DNA Sequencing Market Overview
DNA sequencing refers to determining a DNA molecule's precise order or sequence of nucleotides (adenine, cytosine, guanine, and thymine). It is a fundamental molecular biology and genetics technique that allows scientists to unravel the genetic code within an organism's DNA.